Wednesday, July 8, 2026

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

Assembly Biosciences is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker ASMB. Primary therapeutic focus areas include Chronic Hepatitis B, Recurrent Genital Herpes Simplex

2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Clinical program

ABI-1179

Phase 1 · small molecule · Recurrent Genital Herpes Simplex Type 2

ABI-1179 for Recurrent Genital Herpes Simplex Type 2 is a Phase 1 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

← All ASSEMBLY BIOSCIENCES, INC. projects Phase 1 small molecule completed

Internal code ABI-1179-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ASSEMBLY BIOSCIENCES, INC.
Phase
Phase 1
Modality
small_molecule
Indication
Recurrent Genital Herpes Simplex Type 2
Status
completed
Trials
1

Clinical trials